BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Llibre A, Shimakawa Y, Mottez E, Ainsworth S, Buivan TP, Firth R, Harrison E, Rosenberg AR, Meritet JF, Fontanet A, Castan P, Madejón A, Laverick M, Glass A, Viana R, Pol S, McClure CP, Irving WL, Miele G, Albert ML, Duffy D. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus. Gut 2018;67:2017-24. [PMID: 29615488 DOI: 10.1136/gutjnl-2017-315783] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Sugrue JA, O’farrelly C. Uncovering Resistance to Hepatitis C Virus Infection: Scientific Contributions and Unanswered Questions in the Irish Anti-D Cohort. Pathogens 2022;11:306. [DOI: 10.3390/pathogens11030306] [Reference Citation Analysis]
2 Lledó G, Benítez-Gutiérrez L, Arias A, Requena S, Cuervas-Mons V, de Mendoza C. Benefits of hepatitis C cure with antivirals: why test and treat? Future Microbiol 2019;14:425-35. [PMID: 30900911 DOI: 10.2217/fmb-2019-0041] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chevaliez S, Pawlotsky J. New virological tools for screening, diagnosis and monitoring of hepatitis B and C in resource-limited settings. Journal of Hepatology 2018;69:916-26. [DOI: 10.1016/j.jhep.2018.05.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 12.0] [Reference Citation Analysis]
4 A H, L M, Am J, M M, Gp A, S V. Community-Based Assessment and Treatment of Hepatitis C Virus-Related Liver Disease, Injecting Drug and Alcohol Use Amongst People Who Are Homeless: A Systematic Review and Meta-Analysis. Int J Drug Policy 2021;:103342. [PMID: 34210551 DOI: 10.1016/j.drugpo.2021.103342] [Reference Citation Analysis]
5 Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. J Hepatol 2019;71:62-70. [PMID: 30797050 DOI: 10.1016/j.jhep.2019.02.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
6 Duchesne L, Hejblum G, Njouom R, Touré Kane C, Toni TD, Moh R, Sylla B, Rouveau N, Attia A, Lacombe K. Model-based cost-effectiveness estimates of testing strategies for diagnosing hepatitis C virus infection in Central and Western Africa. PLoS One 2020;15:e0238035. [PMID: 32833976 DOI: 10.1371/journal.pone.0238035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Llibre A, Shimakawa Y, Duffy D. Potential utility of the Genedrive point-of-care test for HCV RNA detection. Gut 2019;68:1903-4. [PMID: 30244200 DOI: 10.1136/gutjnl-2018-317218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cordie A, Mohamed R, Sonderup MW, Wendy Spearman C, Medhat MA, Debzi N, Desalegn H, Esmat G. Hepatitis C elimination in Africa: Seizing the moment for hepatitis-C free future. Arab J Gastroenterol 2021;22:249-51. [PMID: 34531133 DOI: 10.1016/j.ajg.2021.07.002] [Reference Citation Analysis]
9 Adeboyejo K, Grosche VR, José DP, Ferreira GM, Shimizu JF, King BJ, Tarr AW, Soares MMCN, Ball JK, Mcclure CP, Jardim ACG. Simultaneous determination of HCV genotype and NS5B resistance associated substitutions using dried serum spots from São Paulo state, Brazil. Access Microbiology 2022;4. [DOI: 10.1099/acmi.0.000326] [Reference Citation Analysis]
10 Cooke GS, Andrieux-Meyer I, Applegate TL, Atun R, Burry JR, Cheinquer H, Dusheiko G, Feld JJ, Gore C, Griswold MG, Hamid S, Hellard ME, Hou J, Howell J, Jia J, Kravchenko N, Lazarus JV, Lemoine M, Lesi OA, Maistat L, McMahon BJ, Razavi H, Roberts T, Simmons B, Sonderup MW, Spearman CW, Taylor BE, Thomas DL, Waked I, Ward JW, Wiktor SZ; Lancet Gastroenterology & Hepatology Commissioners. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135-184. [PMID: 30647010 DOI: 10.1016/s2468-1253(18)30270-x] [Cited by in Crossref: 180] [Cited by in F6Publishing: 79] [Article Influence: 90.0] [Reference Citation Analysis]
11 Lemoine M, Lacombe K. HCV core antigen: toward elimination of nucleic acid testing? Lancet Gastroenterol Hepatol 2018;3:817-8. [PMID: 30274835 DOI: 10.1016/S2468-1253(18)30305-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
12 Srisomwat C, Yakoh A, Avihingsanon A, Chuaypen N, Tangkijvanich P, Vilaivan T, Chailapakul O. An alternative label-free DNA sensor based on the alternating-current electroluminescent device for simultaneous detection of human immunodeficiency virus and hepatitis C co-infection. Biosens Bioelectron 2021;196:113719. [PMID: 34706315 DOI: 10.1016/j.bios.2021.113719] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
13 Witkowska McConnell W, Davis C, Sabir SR, Garrett A, Bradley-Stewart A, Jajesniak P, Reboud J, Xu G, Yang Z, Gunson R, Thomson EC, Cooper JM. Paper microfluidic implementation of loop mediated isothermal amplification for early diagnosis of hepatitis C virus. Nat Commun 2021;12:6994. [PMID: 34848705 DOI: 10.1038/s41467-021-27076-z] [Reference Citation Analysis]
14 Bajis S, Applegate TL, Grebely J, Matthews GV, Dore GJ. Novel Hepatitic C Virus (HCV) Diagnosis and Treatment Delivery Systems: Facilitating HCV Elimination by Thinking Outside the Clinic. J Infect Dis 2020;222:S758-72. [PMID: 33245354 DOI: 10.1093/infdis/jiaa366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Mohamed Z, Mbwambo J, Rwegasha J, Mgina N, Doulla B, Mwakale P, Tuaillon E, Chevaliez S, Shimakawa Y, Taylor-Robinson SD, Thursz MR, Brown AS, Lemoine M. In-field evaluation of Xpert® HCV viral load Fingerstick assay in people who inject drugs in Tanzania. Liver Int 2020;40:514-21. [PMID: 31778282 DOI: 10.1111/liv.14315] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
16 Pattarabanjird T, Cress C, Nguyen A, Taylor A, Bekiranov S, McNamara C. A Machine Learning Model Utilizing a Novel SNP Shows Enhanced Prediction of Coronary Artery Disease Severity. Genes (Basel) 2020;11:E1446. [PMID: 33271747 DOI: 10.3390/genes11121446] [Reference Citation Analysis]
17 Gómez L, Reygosa C, Morales-arráez DE, Ramos R, Pérez A, Hernández A, Quintero E, Gutiérrez F, Diaz-flores F, Hernández-guerra M. Evaluación de la precisión diagnóstica del sistema Cobas 6800 para la detección de los niveles de viremia del virus de la hepatitis C a partir de muestras de gotas de sangre seca en papel de filtro. Enfermedades Infecciosas y Microbiología Clínica 2020;38:267-74. [DOI: 10.1016/j.eimc.2019.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Kileng H, Gutteberg T, Goll R, Paulssen EJ. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study. BMC Infect Dis 2019;19:189. [PMID: 30808290 DOI: 10.1186/s12879-019-3832-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Coyer L, Njoya O, Njouom R, Mossus T, Kowo MP, Essomba F, Boers A, Coutinho R, Ondoa P; HEP C-IMPACT Team. Achieving a high cure rate with direct-acting antivirals for chronic Hepatitis C virus infection in Cameroon: a multi-clinic demonstration project. Trop Med Int Health 2020;25:1098-109. [PMID: 32502290 DOI: 10.1111/tmi.13450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Agarwal R, Gupta E, Kumar G, Singh KK, Sharma MK. Evaluation of true point of care molecular assay using fingerstick capillary whole blood for diagnosis of hepatitis C infection. J Med Microbiol 2021;70. [PMID: 33704042 DOI: 10.1099/jmm.0.001332] [Reference Citation Analysis]
21 Saludes V, Antuori A, Lazarus JV, Folch C, González-Gómez S, González N, Ibáñez N, Colom J, Matas L, Casabona J, Martró E. Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject drugs in Catalonia, Spain. Int J Drug Policy 2020;80:102734. [PMID: 32470849 DOI: 10.1016/j.drugpo.2020.102734] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
22 Narayanamurthy V, Jeroish ZE, Bhuvaneshwari KS, Samsuri F. Hepatitis C virus (HCV) diagnosis via microfluidics. Anal Methods 2021;13:740-63. [PMID: 33511975 DOI: 10.1039/d0ay02045a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Thedja MD, Wibowo DP, El-Khobar KE, Ie SI, Setiawan L, Murti IS, Muljono DH; Turyadi. Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia. Am J Trop Med Hyg 2021:tpmd201588. [PMID: 33999849 DOI: 10.4269/ajtmh.20-1588] [Reference Citation Analysis]
24 Meyer T, Eberle J, Roß RS, Schüttler CG, Baier M, Buder S, Kohl PK, Münstermann D, Hagedorn HJ, Nick S, Jansen K, Bremer V, Mau M, Brockmeyer NH. [Rapid diagnosis of sexually transmitted infections : Joint statement of DSTIG, RKI, and PEI, as well as the reference centers for HIV, HBV, and HCV and consulting laboratories for Chlamydia, gonococci, and Treponema pallidum]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2020;63:1271-86. [PMID: 32930821 DOI: 10.1007/s00103-020-03218-4] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Tang W, Tao Y, Fajardo E, Reipold EI, Chou R, Tucker JD, Easterbrook P. Diagnostic Accuracy of Point-of-Care HCV Viral Load Assays for HCV Diagnosis: A Systematic Review and Meta-Analysis. Diagnostics 2022;12:1255. [DOI: 10.3390/diagnostics12051255] [Reference Citation Analysis]
26 Byrne C, Radley A, Inglis SK, Beer LJZ, Palmer N, Pham MD, Healy B, Doyle JS, Donnan P, Dillon JF. Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV). BMJ Open 2020;10:e036501. [PMID: 32868356 DOI: 10.1136/bmjopen-2019-036501] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lemoine M, Tillmann HL. What is required from HCV point-of-care tests to reduce the burden of hepatitis C infection? 'Development and clinical validation of the genedrive point-of-care test for qualitative detection of hepatitis C virus'. Gut 2018;67:1916-7. [PMID: 29959169 DOI: 10.1136/gutjnl-2018-316438] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
28 Zidovec Lepej S, Poljak M. Portable molecular diagnostic instruments in microbiology: current status. Clinical Microbiology and Infection 2020;26:411-20. [DOI: 10.1016/j.cmi.2019.09.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
29 Tran TH, Nguyen BT, Nguyen TA, Pham TTP, Nguyen TTT, Mai HTB, Pham HB, Nguyen TM, Phan HTT, Do NT, Ait-Ahmed M, Taieb F, Madec Y. Dried blood spots perform well to identify patients with active HCV infection in Vietnam. J Viral Hepat 2020;27:514-9. [PMID: 31981287 DOI: 10.1111/jvh.13263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Vento S, Dzudzor B, Cainelli F, Tachi K. Liver cirrhosis in sub-Saharan Africa: neglected, yet important. Lancet Glob Health 2018;6:e1060-1. [PMID: 30219314 DOI: 10.1016/S2214-109X(18)30344-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
31 Lamoury FMJ, Njouom R, Amougou-Atsama M, Yiagnigni Mfopou E, Berishvili N, Sologashvili M, Fajardo E, Malobela A, Macé A, Chirehwa M, Alkhazashvili M, Ivanova Reipold E. Diagnostic Performance and Usability of the Genedrive® HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia. Diagnostics (Basel) 2021;11:746. [PMID: 33921930 DOI: 10.3390/diagnostics11050746] [Reference Citation Analysis]
32 Parlati L, Hollande C, Pol S. Treatment of hepatitis C virus infection. Clin Res Hepatol Gastroenterol. 2020;101578. [PMID: 33272891 DOI: 10.1016/j.clinre.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Harrington PR, Komatsu TE, Sun H, Naeger LK. Hepatitis C Virus RNA Levels Following Virologic Failure With Direct-acting Antivirals: Implications for Lower Sensitivity Diagnostic Assays. Clin Infect Dis 2020;70:327-30. [PMID: 31075159 DOI: 10.1093/cid/ciz385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Calvaruso V, Bronte F, Ferraro D, Reina G, Conte E, Rini F, Magro B, Petta S, Di Marco V, Craxì A. Point-of-care HCV RNA testing in the setting of DAA therapy: HCV-FiS (HEpatitis C Virus Fingerstick Study). Liver Int 2019;39:2240-3. [PMID: 31502755 DOI: 10.1111/liv.14242] [Reference Citation Analysis]
35 Morales-Arraez D, Nieto Bujalance Y, Diaz-Flores F, de Vera A, Jiménez A, Garcia Dopico JA, Quintero E, Hernández-Guerra M. Risk of liver fibrosis progression in patients with suboptimal diagnosis of hepatitis C virus infection. Eur J Gastroenterol Hepatol 2020;32:528-34. [PMID: 31490420 DOI: 10.1097/MEG.0000000000001534] [Reference Citation Analysis]
36 Minardi D, Bateman KS, Kuzdzal A, Stone M, Avant J, Condliffe R, Brotherton P, Laverick M, Sritunyalucksana K, Itsathitphaisarn O, Baoprasertkul P, Stentiford GD. Testing of a pond-side molecular diagnostic tool for the detection of white spot syndrome virus in shrimp aquaculture. J World Aquacult Soc 2019;50:18-33. [DOI: 10.1111/jwas.12558] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
37 Hollande C, Parlati L, Pol S. Micro-elimination of hepatitis C virus. Liver Int. 2020;40 Suppl 1:67-71. [PMID: 32077601 DOI: 10.1111/liv.14363] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
38 Leathers JS, Pisano MB, Re V, van Oord G, Sultan A, Boonstra A, Debes JD. Validation of a point-of-care rapid diagnostic test for hepatitis C for use in resource-limited settings. Int Health 2019;11:314-5. [PMID: 30860259 DOI: 10.1093/inthealth/ihy101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]